To buy enough theyd either have the cash or get a loan? Why not just use a debt facility then to fund their needs for the trial. The terms are set and known, the risks can be mananged (as oppossed to fluctuating share price) and planned for, non dilutionary etc.
Ann: PharmAust to present at NWR Virtual Healthcare Conference, page-41
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
-0.005(2.33%) |
Mkt cap ! $85.12M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 21.5¢ | 21.0¢ | $63.69K | 302.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 58135 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 79836 | 4 |
View Market Depth
| Last trade - 10.41am 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
21.0¢ |
Change
-0.005 ( 1.87 %) |
||||
| Open | High | Low | Volume | ||
| 21.0¢ | 21.5¢ | 21.0¢ | 173078 | ||
| Last updated 11.02am 04/06/2024 ? | |||||
| PAA (ASX) Chart |